Integration of Whole Genome Sequencing into Clinical Medicine

全基因组测序融入临床医学

• 批准号: 8236471
• 负责人: Robert C. Green
• 金额: $ 241.08万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-12-05 至 2015-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8236471
• 关键词: Age; Algorithms; Attitude; Behavior; Behavioral; Categories; Clinical; Clinical Medicine; Clinical Trials; Collaborations; Consent; Data; Disclosure; Disease; Disease model; Electronics; Enrollment; Familial Hypertrophic Cardiomyopathy; Family; Future; Genes; Genetic Variation; Genetic screening method; Genomics; Health; Health Care Costs; Human Genetics; Hypertrophic Cardiomyopathy; Individual; Laboratories; Medical; Medicine; Methods; Modeling; Monitor; Motivation; Outcome; Patient Care; Patients; Physicians; Prevention; Primary Care Physician; Process; Protocols documentation; Psychological Impact; Randomized; Randomized Clinical Trials; Recording of previous events; Recruitment Activity; Reporting; Research; Risk; Safety; Sequence Analysis; Symptoms; Test Result; Testing; Update; Variant; arm; base; clinical care; clinical practice; clinically relevant; experience; genome sequencing; health economics; insight; middle age; novel; preference; response; standard of care

DESCRIPTION (provided by applicant): In this highly collaborative multi-disciplinary initiative, we propose to explore and compare the impact of using WGS in clinical conditions that model pure forms of each of these approaches. To model General Genomic Medicine, 10 primary care physicians and 100 of their healthy middle-aged patients will be enrolled. To model Disease-Specific Genomic Medicine, 10 cardiologists and 100 of their patients presenting with familial hypertrophic cardiomyopathy (HCM) will be enrolled. We will conduct an exploratory clinical trial randomizing physicians and their patients within each of these models to receive clinically meaningful information derived from WGS versus current standard of care. Project 1 will create standards for variant disclosure, enroll physicians and patients into the protocol and safely monitor the use of genomic information in clinical practice. Project 2 will sequence, analyze and interpret WGS for the physicians to use. And Project 3 will examine preferences and motivations of physicians and patients enrolled, evaluate the flow and utilization of genomic information within the clinical interactions, and assess understanding, behavior, medical consequences and healthcare costs associated with the use of WGS in these models of medical practice. This initiative will significantly accelerate the use of genomics into clinical medicine by creating and safely testing novel ways of integrating information from WGS into physician care of patients. PUBLIC HEALTH RELEVANCE: Physicians will soon use WGS to derive insight into future health risks and inform prevention efforts in healthy patients and to interrogate particular sets o genes known to be associated with disease in patients presenting with a family history and symptoms. The results of this study will accelerate the use of genomics in clinical medicine by creating and testing ways to integrate WGS into physician care of patients.

描述（由申请人提供）：在这个高度协作的多学科计划中，我们建议探索和比较在模拟这些方法的纯形式的临床条件中使用WGS的影响。为了模拟普通基因组医学，将招募10名初级保健医生和100名健康的中年患者。为了模拟疾病特异性基因组医学，将招募10名心脏病专家和100名家族性肥厚型心肌病（HCM）患者。 我们将进行一项探索性临床试验，在这些模型中随机分配医生及其患者，以获得来自WGS与当前标准治疗的有临床意义的信息。 项目1将为变异披露制定标准，将医生和患者纳入方案，并安全地监测基因组信息在临床实践中的使用。项目2将对WGS进行测序、分析和解释，供医生使用。项目3将检查医生和患者的偏好和动机，评估临床相互作用中基因组信息的流动和利用，并评估在这些医疗实践模式中使用WGS相关的理解，行为，医疗后果和医疗成本。 这一举措将大大加快基因组学在临床医学中的应用， 安全地测试将来自WGS的信息整合到患者的医生护理中的新方法。 公共卫生相关性：医生很快将使用WGS来深入了解未来的健康风险，并为健康患者的预防工作提供信息，并询问已知与有家族史和症状的患者的疾病相关的特定基因组。这项研究的结果将加速基因组学在临床医学中的应用，通过创建和测试将WGS整合到患者的医生护理中的方法。